# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-011236
Filing Date
2021-04-01
Accepted
2021-04-01 16:12:29
Documents
8
Period of Report
2021-05-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF14A | nc10021629x1_def14a.htm | DEF 14A | 991360
2 |  | nc10021629x1_img01.jpg | GRAPHIC | 104749
3 |  | nc10021629x1_img02.jpg | GRAPHIC | 35740
4 |  | nc10021629x1_img03.jpg | GRAPHIC | 36215
5 |  | nc10021629x1_img04.jpg | GRAPHIC | 39211
6 |  | nc10021629x1_img05.jpg | GRAPHIC | 42936
7 |  | nc10021629x1_img06.jpg | GRAPHIC | 333986
8 |  | nc10021629x1_img07.jpg | GRAPHIC | 251353
| Complete submission text file | 0001140361-21-011236.txt |  | 2148891

Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30739 | Film No.: 21798110
SIC: 2834 Pharmaceutical Preparations